About Elizabeth Fitchett

Global Child Health and Infectious Diseases

Dr. Elizabeth Fitchett's research extensively addresses vulnerabilities in paediatric care during pandemics and outbreaks. She co-authored on the COVID-19 pandemic's impact on general pediatric wards, highlighting adaptations like using PICU for adults [1]. Her work on measles diagnostics prioritizes rapid tests for high-burden, fragile settings [6], including collaborative innovation in Senegal with Institut Pasteur de Dakar to tackle global measles challenges [8][13].

Research Funding and Priorities

Fitchett analyzes funding landscapes for critical areas. She contributed to studies on research funding for newborn health and stillbirths from 2011-20, affiliated with London School of Hygiene & Tropical Medicine [2]. Broader priorities include sustainable care for children with cancer, advocating for resource allocation in low-income settings [5].

Diagnostics and Rapid Testing Development

A key focus is accelerating diagnostics for infectious diseases. Recent priorities outline needs for new rapid diagnostic tests, emphasizing paediatric and global health applications [6]. Her ORCID profile lists ongoing work in microbiology and diagnostics [7].

Clinical Leadership and Professional Roles

As Clinical Lead and Board Director at DIATROPIX | Global Access Health, Fitchett drives clinical studies and innovation [8][13][19]. A Kennedy Scholar (Class of 2015, Harvard SPH MPH), she bridges academia and impact-driven careers [3]. Her Twitter (@LibbyFitchett) shares insights as a paediatric doctor and global health researcher [19].

Paediatric Workforce and Retention

Fitchett explores human factors in paediatrics, co-authoring on understanding why paediatric doctors consider leaving, based on qualitative insights [14].

Broader Health Equity and Cancer Care

She contributes to multidisciplinary efforts on soluble triggering receptors and cancer sustainability, linking data analytics to policy [4][5].